NPs Basic Information

Name
2',6'-Dihydroxyacetophenone
Molecular Formula C8H8O3
IUPAC Name*
1-(2,6-dihydroxyphenyl)ethanone
SMILES
CC(=O)C1=C(C=CC=C1O)O
InChI
InChI=1S/C8H8O3/c1-5(9)8-6(10)3-2-4-7(8)11/h2-4,10-11H,1H3
InChIKey
YPTJKHVBDCRKNF-UHFFFAOYSA-N
Synonyms
2',6'-Dihydroxyacetophenone; 699-83-2; 1-(2,6-Dihydroxyphenyl)ethanone; 2,6-Dihydroxyacetophenone; 2-Acetylresorcinol; Resorcinol, 2-acetyl-; Ethanone, 1-(2,6-dihydroxyphenyl)-; 1-(2,6-dihydroxyphenyl)ethan-1-one; 2,6-dihydroxy acetophenone; gamma-Resacetophenone; 1,3-Benzenediol, 2-acetyl-; .gamma.-Resacetophenone; Acetophenone, 2',6'-dihydroxy-; MFCD00002270; NSC 615; 2, 6-Dihydroxyacetophenone; Acetyl-2,6-dihydroxybenzene; 2',6'-dihydroxy-acetophenone; CHEMBL454739; 2-Acetyl-1,3-dihydroxybenzene; NSC-615; 88BO51G3Y2; 1-(2,6-dihydroxyphenyl)-ethanone; 1-(2,6-dihydroxy-phenyl)-ethanone; 1-[2,6-bis(oxidanyl)phenyl]ethanone; 1-(2,6-Dihydroxyphenyl)ethanone (2',6'-Dihydroxyacetophenone); UNII-88BO51G3Y2; EINECS 211-833-6; 2-Acetyl-Resorcinol; mono acetyl resorcinol; 2-ACETYL RESORCINOL; EC 211-833-6; Acetophenone,6'-dihydroxy-; 2-Acetyl-1,3-Benzenediol; dihydroxyacetophenone(2,6-); 2`,6`-Dihydroxyacetophenone; Ethanone,6-dihydroxyphenyl)-; BIDD:ER0607; SCHEMBL105807; 2',6'-dihydroxy acetophenone; NSC615; (2',6'-dihydroxy)acetophenone; 2'',6''-dihydroxyacetophenone; 2\',6\'-Dihydroxyacetophenone; laquo gammaRaquo -resacetophenone; YPTJKHVBDCRKNF-UHFFFAOYSA-; DTXSID00220185; CHEBI:173644; ZINC157768; ACT00503; AMY21894; HY-Y0106; 2',6'-Dihydroxyacetophenone, 97%; BDBM50249071; CK2557; STL195537; ACETOPHENONE, 2,6-DIHYDROXY-; AKOS000299253; CS-W019984; FS-2546; 1-(2,6-Dihydroxyphenyl)ethanone, 9CI; NCGC00166008-01; AC-10724; Acetophenone, 2',6'-dihydroxy- (8CI); SY001633; DB-020214; D1716; FT-0610665; Ethanone, 1-(2,6-dihydroxyphenyl)- (9CI); 99D832; D-3400; EN300-114470; A836723; AB-131/40185723; SODIUM CROMOGLICATE IMPURITY A [EP IMPURITY]; W-203531; Q27269919; Z1255485184; 2',6'-Dihydroxyacetophenone, matrix substance for MALDI-MS, >=99.5%; 2 inverted exclamation mark ,6 inverted exclamation mark -Dihydroxyacetophenone; 2',6'-Dihydroxyacetophenone, matrix substance for MALDI-MS, >=99.5% (HPLC), Ultra pure; 9EQ
CAS 699-83-2
PubChem CID 69687
ChEMBL ID CHEMBL454739
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic oxygen compounds
      • Class: Organooxygen compounds
        • Subclass: Carbonyl compounds
          • Direct Parent: Alkyl-phenylketones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 152.15 ALogp: 1.4
HBD: 2 HBA: 3
Rotatable Bonds: 1 Lipinski's rule of five: Accepted
Polar Surface Area: 57.5 Aromatic Rings: 1
Heavy Atoms: 11 QED Weighted: 0.603

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.607 MDCK Permeability: 0.00001730
Pgp-inhibitor: 0.001 Pgp-substrate: 0.001
Human Intestinal Absorption (HIA): 0.008 20% Bioavailability (F20%): 0.326
30% Bioavailability (F30%): 0.149

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.187 Plasma Protein Binding (PPB): 87.58%
Volume Distribution (VD): 0.775 Fu: 17.57%

ADMET: Metabolism

CYP1A2-inhibitor: 0.92 CYP1A2-substrate: 0.549
CYP2C19-inhibitor: 0.227 CYP2C19-substrate: 0.066
CYP2C9-inhibitor: 0.314 CYP2C9-substrate: 0.842
CYP2D6-inhibitor: 0.569 CYP2D6-substrate: 0.415
CYP3A4-inhibitor: 0.428 CYP3A4-substrate: 0.194

ADMET: Excretion

Clearance (CL): 10.327 Half-life (T1/2): 0.846

ADMET: Toxicity

hERG Blockers: 0.014 Human Hepatotoxicity (H-HT): 0.045
Drug-inuced Liver Injury (DILI): 0.599 AMES Toxicity: 0.579
Rat Oral Acute Toxicity: 0.566 Maximum Recommended Daily Dose: 0.03
Skin Sensitization: 0.84 Carcinogencity: 0.667
Eye Corrosion: 0.912 Eye Irritation: 0.992
Respiratory Toxicity: 0.878
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001513 0.641 D07HBX 0.400
ENC002350 0.610 D0V9EN 0.362
ENC002237 0.595 D0BA6T 0.360
ENC004796 0.568 D0U0OT 0.353
ENC000390 0.568 D0C4YC 0.349
ENC000404 0.559 D01WJL 0.349
ENC000060 0.514 D08HVR 0.347
ENC000344 0.487 D0P7JZ 0.340
ENC000021 0.457 D0I3RO 0.333
ENC002213 0.422 D0Y6KO 0.316
*Note: the compound similarity was calculated by RDKIT.